cilostazol has been researched along with Blood Poisoning in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Whether cilostazol (6-[4-(1-cyclohexyl-1H-tetrazol-5-yl) butoxy]-3,4-dihydro-2-(1H)-quinolinone), anticoagulant, protects mice against sepsis and underlying mechanism(s) were investigated." | 3.81 | Cilostazol inhibits HMGB1 release in LPS-activated RAW 264.7 cells and increases the survival of septic mice. ( Chang, KC, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nomura, K | 1 |
| Miyashita, T | 1 |
| Yamamoto, Y | 1 |
| Munesue, S | 1 |
| Harashima, A | 1 |
| Takayama, H | 1 |
| Fushida, S | 1 |
| Ohta, T | 1 |
| Chang, KC | 1 |
2 other studies available for cilostazol and Blood Poisoning
| Article | Year |
|---|---|
Citrullinated Histone H3: Early Biomarker of Neutrophil Extracellular Traps in Septic Liver Damage.
Topics: Animals; Biomarkers; Cilostazol; Citrullination; Extracellular Traps; Histones; Lipopolysaccharides; | 2019 |
Cilostazol inhibits HMGB1 release in LPS-activated RAW 264.7 cells and increases the survival of septic mice.
Topics: Animals; Anticoagulants; Cilostazol; Dose-Response Relationship, Drug; Heme Oxygenase-1; HMGB1 Prote | 2015 |